We will be carrying out essential maintenance on our website from 12:30pm (GMT) until 2:00pm (GMT) on Monday, 17 January 2022. During this downtime, you will not be able to book courses, exams or events, complete applications to training programmes, or make online payments. We apologise for the inconvenience.

Frequently Asked Questions about COVID-19 vaccines for people with pre-existing allergic conditions

Frequently Asked Questions about COVID-19 vaccines for people with pre-existing allergic conditions

Updated 17 December 2021

The National Immunisation Advisory Committee (NIAC) together with the Irish Association of Allergy and Immunology (IAAI) have produced a Frequently Asked Questions (FAQ) document about COVID-19 vaccines for people with pre-existing allergic conditions.

The Frequently Asked Questions (FAQ) document, available to view and download below, has been created as supplemental information to aid vaccinators and other front-line healthcare professionals (GPs, Occupational Health etc.). The document provides information on how to advise individuals according to their specific allergy history. This document provides guidance regarding four COVID-19 vaccines: Comirnaty (Pfizer-BioNTech), Spikevax (formerly COVID-19 Vaccine Moderna), COVID-19 Vaccine Janssen
and Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).

Frequently Asked Questions about COVID-19 vaccines for people with pre-existing allergic conditions

Updated 17 December 2021